BamSEC and AlphaSense Join Forces
Learn More

Riot Platforms Inc.

NASDAQ: RIOT    
Share price (11/22/24): $12.31    
Market cap (11/22/24): $4.091 billion
Search in Documents
Key Exhibits
External Links

Transcripts

CY 2024
Earnings Revised 11/03/24 Riot Platforms, Inc., Q3 2024 Earnings Call, Oct 30, 2024 10/30/24 Earnings Revised 08/21/24 Riot Platforms, Inc., Q2 2024 Earnings Call, Jul 31, 2024 07/31/24 Earnings Revised 06/13/24 Riot Platforms, Inc., Q1 2024 Earnings Call, May 01, 2024 05/01/24
CY 2022
Other Revised 12/14/22 Riot Blockchain, Inc. - Special Call 12/14/22
CY 2021
Other Revised 05/27/21 Riot Blockchain, Inc., Whinstone US, Inc. - M&A Call 05/27/21 Other Revised 04/08/21 Riot Blockchain, Inc., Whinstone US, Inc. - M&A Call 04/08/21
CY 2020
Other Revised 11/12/20 Riot Blockchain, Inc. - Shareholder/Analyst Call 11/12/20
CY 2016
Other Revised 09/14/16 BiOptix Inc., Venaxis, Inc. - M&A Call 09/14/16 Other Revised 01/27/16 Strand Life Sciences Private Limited, Venaxis, Inc. - M&A Call 01/27/16
CY 2015
Other Revised 06/24/15 Venaxis, Inc. - Shareholder/Analyst Call 06/24/15 Other Revised 04/07/15 Venaxis, Inc. - Special Call 04/07/15 Other Revised 02/13/15 Venaxis, Inc. - Special Call 02/13/15
CY 2014
Other Revised 12/08/14 Venaxis, Inc. - Special Call 12/08/14 Other Revised 08/11/14 Venaxis, Inc. - Special Call 08/11/14 Other Revised 03/13/14 Venaxis, Inc. - Special Call 03/13/14
CY 2013
Earnings Revised 11/07/13 Venaxis, Inc., Q3 2013 Earnings Call, Nov 07, 2013 11/07/13 Other Revised 07/16/13 Venaxis, Inc. - Special Call 07/16/13 Earnings Revised 03/26/13 Venaxis, Inc., Q4 2012 Earnings Call, Mar 26, 2013 03/26/13
CY 2012
Earnings Revised 11/13/12 AspenBio Pharma, Inc., Q3 2012 Earnings Call, Nov 13, 2012 11/13/12 Other Revised 09/27/12 AspenBio Pharma, Inc. - Special Call 09/27/12 Other Revised 08/15/12 AspenBio Pharma, Inc. - Special Call 08/15/12
CY 2011
Other Revised 11/28/11 AspenBio Pharma, Inc. - Special Call 11/28/11 Other Revised 10/19/11 AspenBio Pharma, Inc. - Shareholder/Analyst Call 10/19/11
CY 2007
Other Revised 05/22/07 AspenBio Pharma Inc. - Conference Presentation Call 05/22/07